发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 487 |
| England | 302 |
| GERMANY (FED REP GER) | 159 |
| Denmark | 147 |
| Canada | 137 |
| Italy | 137 |
| CHINA MAINLAND | 109 |
| Netherlands | 90 |
| Sweden | 90 |
| Australia | 88 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| ASTRAZENECA | 82 |
| SANOFI-AVENTIS | 78 |
| NOVO NORDISK | 75 |
| UNIVERSITY OF TORONTO | 72 |
| HARVARD UNIVERSITY | 65 |
| UNIVERSITY OF COPENHAGEN | 65 |
| UNIVERSITY OF NOTTINGHAM | 57 |
| UNIVERSITY OF GRONINGEN | 48 |
| UNIVERSITY OF LEICESTER | 45 |
| UNIVERSITY OF LONDON | 45 |
文章引用情况
1
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol2
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE-TIMI 58 trial: A nationwide observational study3
Differential effects of the circadian system and circadian misalignment on insulin sensitivity and insulin secretion in humans4
Epigenetic effects of metformin: From molecular mechanisms to clinical implications5
A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors6
Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: A meta-analysis of cardiovascular outcome trials7
Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial8
Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose-lowering medications9
Long-term efficacy and safety of ertugliflozin monotherapy in patients with inadequately controlled T2DM despite diet and exercise: VERTIS MONO extension study10
Mobile phone applications and self-management of diabetes: A systematic review with meta-analysis, meta-regression of 21 randomized trials and GRADE